Publications
6/16/11 Trade Alert: High-Growth Cancer Drug Stock–UPDATE
(updated with trade rationale) Sell Put Credit Spread on Celgene (NasdaqGS: CELG) “Buy to Open” October $45 Put and “Sell to Open” October $55 Put Option Symbols: CELG111022P45 and CELG111022P55 Limit Order Price: Net credit of $1.80 or more ($180 per spread) Directional View for Underlying Stock: Neutral to slightly bullish Options for Income Portfolio: […]… Read More
6/13/11: Weekly Briefing: Trading Options from a Stock Perspective
Understanding underlying company fundamentals is as important with option investing as it is with straight equities. Here, too, short-term market fluctuations often provide opportunities to establish value-based positions in good businesses…. Read More
6/9/11 Trade Alert: Bullish on Two Megatrends–UPDATE
(Updated with trade rationales) Trade Recommendation No. 1: “Buy to Open” January 2013 $12.50 Call on Cisco Systems (NasdaqGS: CSCO) Option ticker symbol: CSCO130119C12.5 Limit order price: $3.80 or less ($380 per contract) Directional View for Underlying Stock: Bullish Options for Income Portfolio: Growth Current Cisco Stock Price: $15.30 Time Value Premium to Current […]… Read More
6/9/11 Trade Alert: Bullish on Two Megatrends–UPDATE
The first tech stock is added to the Options for Income Growth Portfolio and a conservative income bet on health care rounds out this double-recommendation week.
… Read More
6/8/11: Drug Trial Test Results Disappoint
In my June 2 trade alert, I predicted that United Therapeutics’ (NSDQ: UHTR) FREEDOM-M drug trial results would be a “binary” event–either a big success that catapults the stock price to $80 to $82 or a failure that causes a stock drop to $52 to $54. As is often the case, reality is neither black […]… Read More
6/8/11: Drug Trial Test Results Disappoint
Despite mixed results for a Portfolio holding’s new drug trial, the original trade remains intact.
6/6/11 Weekly Briefing: OFI Portfolio Resilient in Market Downdraft
The market may be struggling, but the Options for Income Portfolios remain poised for profits.
6/2/11 Trade Alert: Biotech Binary Event
Put Credit Spread on United Therapeutics (NasdaqGS: UTHR) “Buy to Open” July $50 Put and “Sell to Open” July $55 Put Option Symbols: UTHR110716P50 and UTHR110716P55 Limit Order Price: Net credit of $1.40 or more ($140 per spread) Directional View for Underlying Stock: Neutral to slightly bullish Options for Income Portfolio: Conservative Income Margin requirement […]… Read More
6/2/11 Trade Alert: Biotech Binary Event
Imminent test results for a profitable biotech company’s key drug present an option trade opportunity that’s too good to pass up…. Read More
5/31/11 Weekly Briefing: Using Option Spreads as Bearish Hedges
Four consecutive weeks of declines for the S&P 500 have rattled nerves. Stay the course. Options allow investors to profit in both up and down markets…. Read More
« Previous 1 … 409 410 411 412 413 … 419 Next »